CULLINAN THERAPEUTICS, INC. (CGEM) Operating cash flow 2020–2025
CULLINAN THERAPEUTICS, INC. (CGEM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$175.8MFY2025 · since FY2020: -$29.8M → -$175.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$175.8M | -21.0% |
| FY2024 | -$145.3M | -8.2% |
| FY2023 | -$134.3M | -6.0% |
| FY2022 | -$126.7M | -191.6% |
| FY2021 | -$43.4M | -45.9% |
| FY2020 | -$29.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CGEM financial trends
CGEM RevenueCGEM Net incomeCGEM Net marginCGEM Gross profitCGEM Gross marginCGEM Operating incomeCGEM Operating marginCGEM Free cash flowCGEM Capital expendituresCGEM Return on equityCGEM Stock buybacksCGEM Dividends paidCGEM Total assetsCGEM Total liabilitiesCGEM Shareholders’ equityCGEM overview →